Skip to content
Representative Gary McDowell's Web Site

Sidebar Navigation

Sign up for my E-Newsletter.
Receive news and information about key issues in our district.
Subscribe
View map of district 107.

Office Address
S1486 House Office Building

Mailing Address
P.O. Box 30014
Lansing, MI 48909-7514

Phone: (517) 373-2629
Fax: (517) 373-8429

Toll-Free
(888) REP-GARY
(888) 737-4279

Email
garymcdowell@house.mi.gov

News


News

McDowell: Plan Requires Drug Industry to Report Marketing Expenses

Plan aimed at boosting consumer protections also bans lavish gifts to doctors

LANSING – In a move to increase consumer protection in Michigan and hold drug companies accountable, State Representative Gary McDowell (D-Rudyard) today announced a plan that requires drug companies to fully disclose how they spend their marketing money and bans lavish gifts such as extravagant trips and meals to doctors.

"Michigan citizens cannot afford to have the wealthy drug companies putting profits before people and secrecy ahead of safety," said McDowell, a longtime advocate of drug industry reform. "Every year, big drug companies spend billions on marketing and advertising while neglecting the research and development that could make their drugs better and safer. We must stand up to drug companies and the marketing money they're using for the slick ads to sell more drugs and rake in more profits."

The plan would:

  • Require companies to report all drug advertising and marketing expenditures, including gifts to doctors and other health care workers.
  • Require companies to report research and development expenditures.
  • Ban lavish drug company gifts to doctors and limit gifts to $100 worth a year.
  • Establish a searchable Web site that details drug companies' marketing expenses and gifts to doctors, which would be maintained by the Department of Community Health.

Wealthy drug companies spend more than $21 billion annually on marketing.[1] Merck, maker of the now-banned painkiller Vioxx, spent more than $160 million on an aggressive advertising campaign in 2000; as a result, sales of Vioxx quadrupled to $1.5 billion.[2] Vioxx may have caused heart attacks or cardiac deaths in up to 139,000 Americans, based on Merck's own studies, before it was pulled from shelves in 2004.[3]

"Drug companies should be spending their money on making safer drugs, instead of sending an army of sales reps to sway doctors about new drugs," McDowell said. "By requiring full disclosure, we can help our citizens and their doctors make the right choices, and reduce the risks from dangerous drugs."



[1] Journal of the American Medical Association, Jan. 25, 2006.

[2] 2002 AARP report.

[3] Testimony of David Graham, associate director for science and medicine in the FDA's Office of Drug Safety, before the Senate Finance Committee, Nov. 18, 2004.

 

Copyright:

© 2009 Michigan House Democrats

Our Mailing Address:

P.O. Box 30014 • Lansing, MI 48909-7514

Final Navigation